StockData
Cryo-Cell International Inc logo

Cryo-Cell International Inc (CCEL) stock

CCELNYSEServices-Misc Health & Allied Services, NECFiscal year ends November 30
Financials through Q3 FY2026, quarter ended Aug 31, 2026Last filing: 10-Q on Oct 9, 2026Score 2/30
$4.85−0.55 (-10.19%)

Close on Nov 13, 2026Market cap $39.10MP/E –Yield –

Cryo-Cell International statistics

93 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings
–
Last ex-dividend date
May 21, 2025
Fundamentals through
Aug 31, 2026
Share price as of
Nov 13, 2026

Valuation ratiosIndustry

Market Cap
$39.10M
$1.68B
Enterprise Value
$42.92M
$2.20B
PS Ratio
1.26
1.53
P/FCF Ratio
8.41
19.86
P/OCF Ratio
7.95
14.68

Enterprise valuationIndustry

EV / Sales
1.38
1.67
EV / EBITDA
41.05
16.14
EV / EBIT
226.56
20.51
EV / FCF
9.23
24.49

Share statisticsIndustry

Shares Change (YoY)
-1.39%
2.40%
Shares Change (QoQ)
0.00%
0.33%
Float
5M
34M
Shares Held by Insiders
41.7%
15.4%
Shares Held by Institutions
6.89%
83.6%

Short sellingIndustry

Short Interest
12,075
–
Short Interest Change
70.8%
-0.86%
Short % of Float
0.26%
6.28%
Short % of Shares Outstanding
0.15%
4.21%
Days to Cover
1.40
4.41

Stock price statisticsIndustry

52-Week High
$5.45
–
52-Week Low
$2.72
–
20-Day Moving Average
$4.95
–
50-Day Moving Average
$4.47
–
200-Day Moving Average
$3.76
–
Average True Range (14)
$0.41
–
Price Change (1 Week)
-0.82%
0.23%
Price Change (1 Month)
32.9%
-0.02%
Price Change (3 Months)
31.1%
2.13%
Price Change (6 Months)
34.0%
17.6%
Price Change (YTD)
41.0%
5.22%
Price Change (1 Year)
19.8%
3.75%
Price Change (3 Years)
-11.7%
15.2%
Price Change (5 Years)
-60.9%
-14.6%
Price Change (10 Years)
16.9%
184.8%
Average Volume (10 Days)
8,780
–
Average Volume (20 Days)
8,612
–
Average Volume (90 Days)
20,136
–
Relative Volume
0.71
0.70
Relative Strength Index (14)
51.1
46.0
Volatility (1 Year)
75.7%
64.2%
Beta (5 Years)
0.26
0.76

MarginsIndustry

Gross Margin
78.5%
33.3%
Operating Margin
0.61%
-2.98%
Pretax Margin
-6.13%
2.12%
Profit Margin
-6.25%
-2.01%
EBITDA Margin
3.36%
3.36%
FCF Margin
14.9%
2.98%

Returns on capitalIndustry

Return on Assets (ROA)
-3.10%
-3.10%
Return on Capital Employed (ROCE)
0.40%
0.40%

Financial positionIndustry

Current Ratio
0.86
1.41
Quick Ratio
0.72
0.99
Debt / EBITDA
7.69
2.50
Debt / FCF
1.73
4.01
Net Debt / EBITDA
3.65
2.13
Interest Coverage
0.10
-0.63

GrowthIndustry

Revenue Growth (YoY)
-1.96%
9.63%
FCF Growth (YoY)
-24.8%
-6.64%
Revenue Growth (3Y CAGR)
1.33%
11.3%
Revenue Growth (5Y CAGR)
0.27%
12.6%

EfficiencyIndustry

Asset Turnover
0.50
0.81
Inventory Turnover
11.24
10.99
Revenue Per Employee
$432.31K
$235.26K
Profits Per Employee
-$27.02K
-$5.12K
Employee Count
72
910
WACC
8.34%
8.40%

Income statement (TTM)Industry

Revenue
$31.13M
$638.13M
Gross Profit
$24.45M
$196.31M
Operating Income
$189.42K
-$675.66K
Pretax Income
-$1.91M
-$575.82K
Net Income
-$1.95M
-$1.48M
EBITDA
$1.05M
$1.17M
EPS (Diluted)
-$0.24
-$0.02

Balance sheetIndustry

Total Debt
$8.04M
$258.06M
Net Cash (Debt)
-$3.81M
$203.66K
Net Cash Per Share
-$0.47
$0.00
Equity (Book Value)
-$16.39M
$235.60M
Book Value Per Share
-$2.03
$3.91
Tangible Book Value
-$19.17M
$1.59M
Working Capital
-$2.16M
$30.06M

Cash flow (TTM)Industry

Operating Cash Flow
$4.92M
$25.90M
Capital Expenditures
-$268.87K
-$15.83M
Free Cash Flow
$4.65M
$18.83M
FCF Per Share
$0.58
$0.36

Dividends and yieldsIndustry

Earnings Yield
-4.97%
0.19%
FCF Yield
11.9%
2.55%
FCF Payout Ratio
0.00%
11.9%

Taxes and interestIndustry

Interest Expense
$1.82M
$7.37M
Income Tax
$36.82K
$564.50K

Scores and fair valueIndustry

Altman Z-Score
-0.06
2.24
Piotroski F-Score
5
5
Beneish M-Score
-3.18
-2.76

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.

PeriodCCELS&P 500DifferenceCCEL per yearS&P 500 per year
1 month+12.8%-3.0%+15.8 pts
3 months+24.5%-2.8%+27.3 pts
Year to date+41.0%+11.5%+29.5 pts
1 year+18.6%+13.5%+5.1 pts
3 years+1.1%+77.7%−76.6 pts+0.4%+21.1%
5 years-51.2%+72.6%−123.8 pts-13.4%+11.5%
10 years+53.1%+308.2%−255.1 pts+4.4%+15.1%

Short interest

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

0M CCEL shares were sold short on Oct 30, 2026, up 70.8% from the previous report, or 0.26% of the shares available to trade. At recent volumes it would take 1.4 days to buy them back. Over the last 20 sessions, 34.5% of the volume reported to FINRA was short selling.

Settlement dateShares shortChangeAvg. daily volumeDays to cover
Oct 30, 202612,075+70.8%8,6541.4
Oct 15, 20267,070+10.2%18,6501.0
Sep 30, 20266,416-29.2%7,8861.0
Sep 15, 20269,061+60.0%18,1601.0
Aug 31, 20265,662-55.5%19,1101.0
Aug 14, 202612,737+41.9%78,8721.0
Jul 31, 20268,977-2.9%10,8921.0
Jul 15, 20269,249+45.2%14,1801.0
Jun 30, 20266,372-35.7%8,4361.0
Jun 15, 20269,904-32.5%3,4282.9
May 29, 202614,674+49.2%9,3611.6
May 15, 20269,834+40.2%7,4121.3

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

See a number that looks wrong?